Maria Afentakis

576 total citations
7 papers, 83 citations indexed

About

Maria Afentakis is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Maria Afentakis has authored 7 papers receiving a total of 83 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Maria Afentakis's work include Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). Maria Afentakis is often cited by papers focused on Estrogen and related hormone effects (4 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (3 papers). Maria Afentakis collaborates with scholars based in United Kingdom, United States and Australia. Maria Afentakis's co-authors include Mitch Dowsett, Janine Salter, Margaret Hills, I. E. Smith, Mónica Arnedos, Jorge S. Reis‐Filho, Roger A’Hern, Jack Cuzick, Ivana Šestak and Maggie C.U. Cheang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Maria Afentakis

7 papers receiving 82 citations

Peers

Countries citing papers authored by Maria Afentakis

Since Specialization

Citations

This map shows the geographic impact of Maria Afentakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Afentakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Afentakis more than expected).

Fields of papers citing papers by Maria Afentakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Afentakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Afentakis. The network helps show where Maria Afentakis may publish in the future.

Co-authorship network of co-authors of Maria Afentakis

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Afentakis. A scholar is included among the top collaborators of Maria Afentakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Afentakis. Maria Afentakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors 2019 ·Clinical Cancer Research ·Mariana Ferreira Leal, Ben P. Haynes, Eugene F. Schuster, Belinda Yeo, Maria Afentakis, Lila Zabaglo, Vera Martins, Richard Buus, Andrew Dodson, Maggie C.U. Cheang, Ian E. Smith, Lesley‐Ann Martin, Mitch Dowsett	13
2	Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy 2017 ·npj Breast Cancer ·Ben P. Haynes, Ophira Ginsburg, Qiong Gao, Elizabeth Folkerd, Maria Afentakis, (unknown), (unknown), (unknown), Nguyễn Văn Định, Ta Van To, Mark Clemons, Ian E. Smith, Mitch Dowsett	1
3	Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas 2016 ·Breast Cancer Research ·(unknown), Elena López‐Knowles, Qiong Gao, Maggie C.U. Cheang, James P. Morden, Joel S. Parker, Lesley‐Ann Martin, (unknown), Fiona E. McNeill, Margaret Hills, Simone Detre, Maria Afentakis, Lila Zabaglo, Andrew Dodson, Anthony Skene, Chris Holcombe, J.F.R. Robertson, A. Ian Smith, Judith M. Bliss, Mitch Dowsett	20
4	Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer 2014 ·Annals of Oncology ·Mónica Arnedos, (unknown), Maria Afentakis, Roger A’Hern, Margaret Hills, Janine Salter, I. E. Smith, Jorge S. Reis‐Filho, Mitch Dowsett	30
5	Immunohistochemical BAG1 expression improves the estimation of residual risk by IHC4 in postmenopausal patients treated with anastrazole or tamoxifen: a TransATAC study 2013 ·Breast Cancer Research and Treatment ·Maria Afentakis, Mitch Dowsett, Ivana Šestak, Janine Salter, Anthony Howell, Aman U. Buzdar, John Forbes, Jack Cuzick	12
6	Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in ER-positive breast cancer. 2010 ·Journal of Clinical Oncology ·Mónica Arnedos, (unknown), Maria Afentakis, Margaret Hills, Janine Salter, I. E. Smith, Mitch Dowsett	4
7	A Breast Cancer-Associated SNP Adjacent to ESR1 Correlates with Oestrogen Receptor-α (ERα) Level in Invasive Breast Tumours. 2009 ·Cancer Research ·Suzanne Drury, Nichola Johnson, Margaret Hills, Janine Salter, Maria Afentakis, Anita K. Dunbier, Elizabeth Folkerd, Julian Peto, Olivia Fletcher, Mitch Dowsett, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact